Germany· DE-A57-3fadee1060a41889
Cytotect Cp
A medicinal product containing human cytomegalovirus immunoglobulin, registered in Germany by Biotest Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Human Cytomegalovirus Immunoglobulin
- Manufacturer
- Biotest Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human cytomegalovirus immunoglobulin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumIvegam-CMV 100 mg/mlCentrale Afdeling Voor Fractionering - Departement Central De Fractionnement
- United KingdomCytomegalovirus immunoglobulin human 3g powder for solution for infusion vialsScottish National Blood Transfusion Service
- SpainMEGALOTECT 100 U/ML SOLUCION PARA PERFUSIONBiotest Pharma Gmbh
- CanadaCYTOGAMKI BIOPHARMA LLC
- IrelandMegalotect 100 U/mL solution for infusionBiotest Pharma GmbH
- NetherlandsMegalotect 100 E/ml oplossing voor infusieBiotest Pharma GmbH
- PolandMegalotect CPBiotest Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Cytotect Cp
- Belgium · Megalotect
- Czechia · Cymvigo
- Spain · Megalotect
- United Kingdom (Northern Ireland) · Cytotect Cp
- Greece · Megalotect Cp
- Croatia · Cytotect Cp
- Hungary · Cytotect Cp
- Ireland · Megalotect
- Italy · Cytomegatect
- Lithuania · Cymvigo
- Netherlands · Megalotect
- Poland · Megalotect Cp
- Portugal · Megalotect Cp
- Romania · Cytotect Cp
- Slovenia · Megalotect
- Slovakia · Cytotect
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/857ec28d-cba7-49d0-b674-cef8d66fc4d8 GET /v1/drugs/857ec28d-cba7-49d0-b674-cef8d66fc4d8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Human Cytomegalovirus Immunoglobulin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about human cytomegalovirus immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.